Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesized that dornase alpha, administered twice a day (BID) by in-line
nebulizer, would improve oxygenation, compliance, and time to extubation in adult patients
receiving mechanical ventilation.
Phase:
N/A
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey